Abstract

New quinazolinone derivatives of the marine-derived alkaloids fiscalin B (3) and fumiquinazoline G (1), with neuroprotective and antitumor effects, were synthesized. Eleven quinazolinone-containing indole alkaloids were synthesized, proceeding the anti analogs via a one-pot method, and the syn analogs by the Mazurkiewicz-Ganesan approach. The neuroprotection capacity of these compounds on the rotenone-damage human neuroblastoma cell SH-SY5y was evaluated using the MTT assay. Compounds 1, 3, 5, and 7 showed more than 25% protection. The antitumor activity was investigated using the sulforhodamine B assay and some compounds were tested on the non-malignant MCF-12A cells. Fumiquinazoline G (1) was the most potent compound, with GI50 values lower than 20 µM. Compounds 5, 7, and 11 were more active in all tumor cell lines when compared to their enantiomers. Compounds 5, 7, 10, and 11 had very little effect in the viability of the non-malignant cells. Differences between enantiomeric pairs were also noted as being essential for these activities the S-configuration at C-4. These results reinforce the previously described activities of the fiscalin B (3) as substance P inhibitor and fumiquinazoline G (1) as antitumor agent showing potential as lead compounds for the development of drugs for treatment of neurodegenerative disorders and cancer, respectively.

Highlights

  • IntroductionThe pathophysiology of neurodegenerative diseases is poorly understood, and there are few therapeutic options, making neuroprotective drug discovery appealing for medicinal chemists

  • The pathophysiology of neurodegenerative diseases is poorly understood, and there are few therapeutic options, making neuroprotective drug discovery appealing for medicinal chemists.Molecules 2019, 24, 534; doi:10.3390/molecules24030534 www.mdpi.com/journal/molecules cancer and neurodegeneration have very distinct pathological disorders, over recent years growing evidence indicates that they share common molecular pathways [1]

  • We have described syntheses of a series of fiscalin B derivatives, which showed weak to moderate antitumor activity against non-small cell lung cancer (NCI-H460) and colorectal adenocarcinoma (HCT-15) cell lines [16]

Read more

Summary

Introduction

The pathophysiology of neurodegenerative diseases is poorly understood, and there are few therapeutic options, making neuroprotective drug discovery appealing for medicinal chemists. We have described syntheses of a series of fiscalin B derivatives, which showed weak to moderate antitumor activity against non-small cell lung cancer (NCI-H460) and colorectal adenocarcinoma (HCT-15) cell lines [16]. These findings led us to develop a small library of proteomimetic quinazolinone-derived compounds (Figure 1B) with different configurations at C-1 and C-4 to investigate their action on neurodegenerative disorders as well as to further explore their potential as tumor cell growth inhibitors, putting in evidence the influence of the stereochemistry of the derivatives

Chemistry
Reagents
Figures The
(Supplementary configuration compound
Neuroprotection Activity
Neuroprotective effect of of
Tumor Cell Growth Inhibitory Activity
Activity in Non-Tumor Cells
General Procedure
Neuroprotection Assay
Screening Test for Antitumor Activity
Testing Effect of Compounds on Non-malignant Breast Cells
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call